Author

Claudia Hagedorn

University of Witten/ Herdecke - Cited by 539

Biography

Prof. Dr. Claudia Hagedorn Faculty of Health (Department of Human Medicine) Department of Biochemistry and Molecular Medicine Professorship for Nuclear Architecture and Chromatin Organization in Gene Therapy. SKILLS Matlab, Management, Microsoft Word, Data Analysis, Biowissenschaften, Molekularbiologie, Biotechnology, Cell, Western blot, Biotechnologie, Nuclear Organisation, Epigenetics, Molecular Genetics, Customer Service, Statistics, Gene Therapy, PCR, Western Blotting
Title
Cited by
Year
Circadian hepatocyte clocks keep synchrony in the absence of a master pacemaker in the suprachiasmatic nucleus or other extrahepatic clocks
F Sinturel, P Gos, V Petrenko, C Hagedorn, F Kreppel, KF Storch, D Knutti, ...Genes & development 35 (5-6), 329-334, 2021202
54
2021
Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells
A Kawamura, D Baitsch, R Telgmann, R Feuerborn, G Weissen-Plenz, ...Arteriosclerosis, thrombosis, and vascular biology 27 (7), 1610-1617, 2007200
49
2007
Impact of common KIBRA allele on human cognitive functions
H Wersching, K Guske, S Hasenkamp, C Hagedorn, S Schiwek, S Jansen, ...Neuropsychopharmacology 36 (6), 1296-1304, 2011201
46
2011
S/MAR element facilitates episomal long-term persistence of adeno-associated virus vector genomes in proliferating cells
C Hagedorn, M Schnoedt-Fuchs, P Boehme, H Abdelrazik, HJ Lipps, ...Human gene therapy 28 (12), 1169-1179, 2017201
38
2017
Genomic cis-acting sequences improve expression and establishment of a nonviral vector
C Hagedorn, MN Antoniou, HJ LippsMolecular Therapy-Nucleic Acids 2, 2013201
36
2013
Molecular genetic analysis of a human insulin‐like growth factor 1 promoter P1 variation
R Telgmann, C Dördelmann, E Brand, V Nicaud, C Hagedorn, ...The FASEB Journal 23 (5), 13-1313, 2009200
30
2009
Scaffold/Matrix Attached Region-Based Nonviral Episomal Vectors
C Hagedorn, SP Wong, R Harbottle, HJ LippsHuman gene therapy 22 (8), 915-923, 2011201
29
2011
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study
U Hillebrand, D Lang, RG Telgmann, C Hagedorn, S Reuter, K Kliche, ...Journal of hypertension 27 (3), 517-526, 2009200
28
2009
Controlled removal of a nonviral episomal vector from transfected cells
S Rupprecht, C Hagedorn, D Seruggia, T Magnusson, E Wagner, M Ogris, ...Gene 466 (1-2), 36-42, 2010201
23
2010
Capsid and genome modification strategies to reduce the immunogenicity of adenoviral vectors
F Kreppel, C HagedornInternational Journal of Molecular Sciences 22 (5), 2417, 2021202
19
2021
Functional and structural profiling of the human thrombopoietin gene promoter
C Dordelmann, R Telgmann, E Brand, C Hagedorn, B Schroer, ...Journal of Biological Chemistry 283 (36), 24382-24391, 2008200
17
2008
Capsid engineering of adenovirus vectors: overcoming early vector–host interactions for therapy
C Hagedorn, F KreppelHuman Gene Therapy 28 (10), 820-832, 2017201
15
2017
Viral hybrid-vectors for delivery of autonomous replicons
W Zhang, C Hagedorn, E Schulz, HJ Lipps, A EhrhardtCurrent Gene Therapy (1), 10-23, 202
14
2014
Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter
C Hagedorn, R Telgmann, C Dördelmann, B Schmitz, S Hasenkamp, ...Arteriosclerosis, thrombosis, and vascular biology 29 (10), 1638-1643, 2009200
14
2009
Osteopontin gene variation and cardio/cerebrovascular disease phenotypes
K Schmidt-Petersen, E Brand, R Telgmann, V Nicaud, C Hagedorn, ...Atherosclerosis 206 (1), 209-215, 2009200
14
2009
Characterization and functional analyses of the human G protein–coupled receptor kinase 4 gene promoter
S Hasenkamp, R Telgmann, JA Staessen, C Hagedorn, C Dördelmann, ...Hypertension 52 (4), 737-746, 2008200
12
2008
A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectors
C Hagedorn, A Baiker, J Postberg, A Ehrhardt, HJ LippsCold Spring Harb Protoc 6, 706-708, 202
12
2012
Genetic and chemical capsid modifications of adenovirus vectors to modulate vector–host interactions
D Weklak, D Pembaur, G Koukou, F Jönsson, C Hagedorn, F KreppelViruses 13 (7), 1300, 2021202
10
2021
Handling S/MAR vectors
C Hagedorn, A Baiker, J Postberg, A Ehrhardt, HJ LippsCold Spring Harb. Protoc 2012, 657-663, 2012201
10
2012
pEPI for gene therapy non viral episomes and their application in somatic gene therapy
C Hagedorn, HJ LippsJ Cell Sci Ther S 6, 2, 2011201
8
2011

Referred From: https://scholar.google.de/citations?user=pt-p7qQAAAAJ&hl=en

Cited by
Citations 539
h-index 14
i10-index 20
Recommended Journals
Open Access Journals